Announced Fri, 28 Aug · 21:17 IST
41st Annual Report for FY 2025-26 and AGM Notice filed
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.8%1-day move
₹116.60
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+3.8+3.8+8.1+1.8+4.7+3.8————
Up moveDown movePending
AI summary
Arvaya Healthcare filed its 41st Annual Report for FY 2025-26. AGM is on 21 September 2026 at 3 PM via video conferencing. Agenda includes adopting financial statements, reappointing MD Kaushal Uttam Shah, approving material related party transactions with 9 related parties (Rs 40 to 50 Crore each), and acquiring Copyright and IP from DEFIB Institute of Health Solutions LLP for up to Rs 10 Crore using Rights Issue proceeds.
Likely market impact
Shareholders will vote on financial statements, MD reappointment, related party deals, and an IP acquisition at the AGM on 21 Sept 2026.